This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Myosuit Chronic Stroke Protocol

Sponsored by Fondazione Don Carlo Gnocchi Onlus

About this trial

Last updated 2 years ago

Study ID

MyoSCSP

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 2 years ago

What is this trial about?

A stroke is a vascular condition that can suddenly cause the loss of neurological functions. The disability derived from a stroke can imply reduced communication and limited activities of daily living in the long term. Thus, specifically walking rehabilitation is crucial in order to restore the lower limbs' function and to re-establish the social participation of patients. Robotics has been demonstrated in being a suitable and effective tool in order to assist and treat post-stroke patients, thanks to its capability to deliver intensive and task-oriented training. Specifically, the exosuits, are a sub-group of robotics devices designed in lighter materials that assist the patients by actively moving the hip, knee or ankle. Given this framework, the aim of this work is to conduct a pilot study on the usability and perceived effectiveness of a lower-limb exosuit, the Myosuit device, on post-stroke patients. The secondary aims of the study concern the evaluation of the functional performances of the patients both with and without the device and before and after the treatment.

What are the participation requirements?

Yes

Inclusion Criteria

- Clinical stability, evaluated through the administration of the MEWS scale (Modified Early Warning Score);

- To be able to stand up from a chair without exceeding a trunk angle of 45° to the left or right during the movement;

- To be able to walk for 10 m without the support of another person but, if necessary, with conventional aids different than knee othesis (e.g. stick, crutch, ankle/foot orthesis). The aid considered should have single-support;

- Height between 150 cm and 195 cm;

- Weight between 45 kg and 110 kg;

- FAC (Functional Ambulation Calssification) ≥3;

- MAS (Modified Ashworth Scale) ≤2;

- HADS (Hospital Anxiety and Depression Scale) with normative values (>10/21 for each scale);

- MoCA (Montreal Cognitive Assessment) (Equivalent scoring > 1 with the Italian correction from Santangelo et al._ 2015);

- To be able to understand and sign the informed consent.

No

Exclusion Criteria

- Presence of an active (or with effects) neurological or psychiatric pathology occurred before the vascular event;

- Severe bilateral hearing or sight loss;

- Functional Reach Test <15.24;

- Flexion retruction of hip and knee greater than 10° and not reducible;

- Presence of genu varum or geru valgum greater than 10°;

- Pregnancy;

- Previous stroke.

Locations

Location

Status

Recruiting